REGENXBIO Inc.RGNXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-175.56M
↓ 131% below average
Average (9y)
$-76.13M
Historical baseline
Range
High:$134.70M
Low:$-238.21M
CAGR
+25.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-175.56M | +23.1% |
| 2023 | $-228.37M | +4.1% |
| 2022 | $-238.21M | -276.8% |
| 2021 | $134.70M | +266.4% |
| 2020 | $-80.93M | +32.2% |
| 2019 | $-119.42M | -230.7% |
| 2018 | $91.37M | +240.2% |
| 2017 | $-65.15M | -14.9% |
| 2016 | $-56.71M | -146.2% |
| 2015 | $-23.04M | - |